Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-01
2011-03-01
Kosack, Joseph R (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S232800, C514S236500, C514S326000, C514S306000, C544S140000, C546S138000, C546S199000, C546S211000, C548S359100, C548S359500, C548S360500, C548S362500, C548S361100, C548S360100, C548S364100, C548S376100, C548S377100
Reexamination Certificate
active
07897634
ABSTRACT:
This invention relates to compounds of the formulas (1), (2) and (3) having pharmacological activity, to compositions containing these compounds, and to methods of treatment employing the compounds and compositions.
REFERENCES:
patent: 3940418 (1976-02-01), Hamilton
patent: 7202257 (2007-04-01), Flynn et al.
patent: 2004/0110741 (2004-06-01), Bergmanis et al.
patent: 2005/0080087 (2005-04-01), Pendri et al.
patent: 2005/0256180 (2005-11-01), Bergmanis et al.
patent: 2007/0142434 (2007-06-01), Sandanayaka et al.
patent: 2008/0033013 (2008-02-01), Sandanayaka et al.
patent: 2008/0214545 (2008-09-01), Lee et al.
Chazot, P. L. Current Anaesthesia & Critical Care 2005, 16, 94-98.
Bennani Youssef L.
Campbell Michael G.
Dastrup David
Porter Huck Emile
Athersys, Inc.
Coughlin Matthew P
Kosack Joseph R
Wood Phillips Katz Clark & Mortimer
LandOfFree
Pyrazoles for the treatment of obesity and other CNS disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazoles for the treatment of obesity and other CNS disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazoles for the treatment of obesity and other CNS disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666945